Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

Head of Sandoz UK becomes BGMA chair

May 30, 2018 Manufacturing and Production, Research and Development British Generic Manufacturers Association, biotech, drugs, pharma, pharmaceutical

Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …
News
slimming-2728331_960_720

One in 25 English children are severely obese by secondary school, study finds

May 29, 2018 Manufacturing and Production, Research and Development England, UK, childhood obesity, obesity, pharma

A new analysis of Public Health England figures by the Local Government Association (LGA) has revealed that one in 25 …
News
ema_building_face_web

AB Science will not seek review of masitinib rejection in Europe

May 29, 2018 Manufacturing and Production, Sales and Marketing EMA, Europe, ab science, als, masitinib, pharma

AB Science has U-turned on its pursuit of a do-over on its marketing application of masitinib in Europe after the …
News

Roche’s Tecentriq/chemo combo smashes both co-primary endpoints at Phase 3

May 29, 2018 Manufacturing and Production, Research and Development Cancer, NSCLC, Roche, immunotherapy, lung cancer, pharma, tecentriq

Roche has lifted the curtain on new Phase 3 data for its anti-PD-L1 cancer immunotherapy Tecentriq (atezolizumab), showing that the …
News

UCB’s Cimzia secures first-of-its-kind FDA approval in plaque psoriasis

May 29, 2018 Manufacturing and Production, Sales and Marketing Cimzia, FDA, UCB, US, pharma, psoriasis

The FDA has expanded the label for UCB’s Cimzia (certolizumab pegol) in the US, approving the therapy for the treatment …
News
jj

J&J terminates PD-(L)1 combo studies of cancer therapy Darzalex

May 29, 2018 Manufacturing and Production, Research and Development Cancer, Genmab, J&J, JJ, Johnson & Johnson, Roche, darzalex, multiple myeloma, tecentriq

Johnson & Johnson is to terminate its studies investigating Genmab’s CD38-targeting, human IgG1κ monoclonal antibody Darzalex (daratumumab) in combination with …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Gielad, Novartis, brexit, obesity, pharma, top ten

It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …
News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.
Feature
640px-hiv-budding-color

India, Sweden and The Netherlands form HIV/AIDS research partnership

May 22, 2018 Manufacturing and Production, Research and Development AIDS, HIV, India, Sweden, The Netherlands, pharma

A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …
News

NHS Trust harnesses AI to speed up treatment

May 22, 2018 Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …
News
brothers-457237_960_720

The cause of the most common form of childhood cancer found

May 22, 2018 Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical

Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …
News
landing-hero-images1

ViiV’s two-drug regimen gets EU approval for HIV-1

May 22, 2018 Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma

ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …
News
pills_shot

Nabriva closes in on bringing new class of antibiotic to market

May 22, 2018 Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …
News
gilead-sciences

Gilead expands operations in Cork, Ireland

May 21, 2018 Manufacturing and Production, Sales and Marketing Gilead, Ireland, biotech, drugs, pharma, pharmaceutical

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …
News
shutterstock_349943306

Clinical trials, Brexit and the question of ‘full alignment’

May 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit, clinical trials, feature, pharma

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …
Feature
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026